Herbert Lepor, MD, defines focal ablation and its quality of life, oncological, and cost benefits to patients. He then discusses best practices for the procedure, including optimal patient selection, energy source options, and extent of the ablation zone. Furthermore, he explains the research and improvement needed to make focal ablation of prostate cancer ready for prime time.Read More
Herbert Lepor, MD
NYU Langone Health
New York, NY
Dr. Herbert Lepor, M.D. serves as a Professor and Martin Spatz Chairman of Department of Urology at NYU School of Medicine. His clinical practice is devoted exclusively to surgical management of prostate cancer. He also serves as Chairman of Scientific Advisory Board at UroGen Pharmaceuticals, Ltd., and as a Member of Medical Advisory Board at Skyline Medical Inc. He has served on the editorial boards of four major urological journals and has authored more than 191 peer ”reviewed articles, 50 book chapters and 12 books.
Articles by Herbert Lepor, MD
Posted by Herbert Lepor, MD | Nov 2017
Herbert Lepor, MD, NYU School of Medicine, New York, New York, discusses the advantages of...Read More